首页> 美国卫生研究院文献>Protein Science : A Publication of the Protein Society >Generation of high-affinity fully human anti-interleukin-8 antibodies from its cDNA by two-hybrid screening and affinity maturation in yeast
【2h】

Generation of high-affinity fully human anti-interleukin-8 antibodies from its cDNA by two-hybrid screening and affinity maturation in yeast

机译:通过双杂交筛选和酵母中的亲和力成熟从其cDNA生成高亲和力的全人类抗白介素8抗体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have developed a technology for rapidly generating novel and fully human antibodies by simply using the antigen DNA. A human single-chain variable fragment (scFv) antibody library was constructed in a yeast two-hybrid vector with high complexity. After cloning cDNA encoding the mature sequence of human interleukin-8 (hIL8) into the yeast two-hybrid system vector, we have screened the human scFv antibody library and obtained three distinct scFv clones that could specifically bind to hIL8. One clone was chosen for further improvement by a novel affinity maturation process using the error-prone PCR of the scFv sequence followed by additional rounds of yeast two-hybrid screening. The scFv antibodies of both primary and affinity-matured scFv clones were expressed in E. coli. All purified scFvs showed specific binding to hIL8 in reciprocal coimmunoprecipitation and ELISA assays. All scFvs, as well as a fully human IgG antibody converted from one of the scFv clones and expressed in the mammalian cells, were able to effectively inhibit hIL8 in neutrophil chemotaxis assays. The technology described can generate fully human antibodies with high efficiency and low cost.
机译:我们已经开发出一种技术,可以通过简单地使用抗原DNA来快速生成新颖且完全人源的抗体。在酵母两杂交载体中以高复杂度构建人单链可变片段(scFv)抗体文库。将编码人白介素8(hIL8)成熟序列的cDNA克隆到酵母双杂交系统载体中后,我们筛选了人scFv抗体文库并获得了三个可以特异性结合hIL8的不同scFv克隆。通过使用scFv序列易错PCR的新型亲和力成熟过程,选择一个克隆进行进一步改良,然后再进行几轮酵母双杂交筛选。初生和亲和力成熟的scFv克隆的scFv抗体均在大肠杆菌中表达。在相互的共免疫沉淀和ELISA分析中,所有纯化的scFv均显示与hIL8的特异性结合。所有的scFvs,以及从其中一个scFv克隆转化而来的完全人IgG抗体,都在哺乳动物细胞中表达,能够在嗜中性粒细胞趋化性测定中有效抑制hIL8。所描述的技术可以高效,低成本地产生完全的人类抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号